Malaysia’s government-linked private equity firm Ekuiti Nasional Bhd (Ekuinas) on Wednesday announced that it has acquired a controlling stake in Medispec (M) Sdn Bhd, a local pharma and supplement product distributor, based on an enterprise value of 88.5 million ringgit ($21.87 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
